CYP2C19/质子泵抑制剂警示转为主动非中断式对处方模式的影响
在大型农村卫生系统开展回顾性研究,比较CYP2C19代谢型与PPI处方相关的中断式与非中断式临床决策支持警示的接受率。中断式警示接受率为18.6%(64/344),非中断式警示为8.4%(30/357)(P ≤ 0.0001)。非中断式警示组因剂量调整而接受的比例高于中断式组(53.3% [16/30] 对 4.7% [3/64]),差异有统计学意义(P ≤ 0.00001)。
要点
- 中断式CDS警示的总体接受率高于非中断式警示。
- 非中断式警示更常促成剂量调整而非换药。
- 两组PPI主要适应症均为胃食管反流病。
核心结论
- 主动影响工作流的中断式警示接受率高于仅提供信息而不打断工作流的非中断式警示。
- 非中断式警示可能有助于提示临床医生调整给药方案而非转换为替代药物。
研究设计与样本
- 在大型农村卫生系统开展的回顾性研究。
- 通过人工审阅识别PPI处方时显示的CYP2C19代谢型警示,比较转为非中断式功能前后各30天的数据。
- 采用卡方检验分析不同警示方式和治疗修改类型的接受率。
主要发现
- 中断式警示总体接受率为18.6%(64/344)。
- 非中断式警示总体接受率为8.4%(30/357)(P ≤ 0.0001)。
- 非中断式警示组因记录剂量调整而接受的比例为53.3%(16/30),中断式组为4.7%(3/64)(P ≤ 0.00001)。
- 两组PPI主要适应症均为胃食管反流病(GERD)。
临床怎么用
- 对于需要提示调整PPI剂量的场景,可考虑采用非中断式警示。
- 若目标是促使临床医生更换为替代药物,非中断式警示的效果可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare rates of prescriber acceptance of interruptive and noninterruptive clinical decision support (CDS) alerts regarding potential diminished therapeutic effectiveness and safety risks associated with proton pump inhibitor (PPI) use in carriers of gene variants affecting cytochrome P450 (CYP) isozyme 2C19 metabolism. METHODS: A retrospective study was conducted at a large rural health system to examine different approaches to improving CDS alert acceptance while minimizing alert fatigue. Manual reviews were conducted to identify alerts regarding CYP2C19 metabolizer status displayed at the time of PPI ordering over 30-day periods before and after the transition from interruptive to noninterruptive CDS alert functionality. A chi-square test was conducted to analyze prescriber acceptance of CDS recommendations by alert modality and type of treatment modification. RESULTS: Overall, interruptive alerts had an acceptance rate of 18.6% (64/344), compared to 8.4% acceptance (30/357 alerts) for noninterruptive alerts (P ≤ 0.0001). Analysis of acceptance criteria -revealed the noninterruptive alert cohort had higher acceptance, as determined by documented medication dose adjustments, than the interruptive alert cohort (53.3% [16/30] and 4.7% [3/64], respectively). The difference in acceptance rates by CDS modality and treatment modification was statistically significant (P ≤ 0.00001). The predominant indication for PPI use was gastroesophageal reflux disease (GERD) in both cohorts. CONCLUSION: Interruptive alerts that actively influenced workflow had higher acceptance rates than noninterruptive alerts that served an informational purpose without a direct disruption of workflow. The study results suggest the utilization of noninterruptive alerts may be a beneficial tool for prompting clinicians to alter dosing regimens rather than transition to an alternative agent.
引用
- Massmann A, Petry NJ. Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patterns. Am J Health Syst Pharm. 2023. PMID: 37155711. doi:10.1093/ajhp/zxad100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。